Literature DB >> 3079482

How effective is cytotoxic chemotherapy for disseminated prostatic carcinoma?

M A Eisenberger1, P Kennedy, J Abrams.   

Abstract

Most of the chemotherapeutic agents available for clinical practice have been employed against prostatic cancer, either alone or in combination. Evaluation of the results has been complicated by various factors, not the least of which relates to the nature of the disease itself. In this comprehensive review of the literature, the authors have compiled the results to date.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3079482

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  1 in total

1.  Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy.

Authors:  Satyan K Shah; Donald L Trump; Oliver Sartor; Wei Tan; Gregory E Wilding; James L Mohler
Journal:  J Urol       Date:  2008-12-16       Impact factor: 7.450

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.